Background: Current guidelines for screening of colorectal cancer do not offer specific recommendations for cessation of antithrombotic agents prior to fecal occult blood test (FOBT). Aim ...
and the guaiac-based fecal occult blood test (gFOBT). However, like any screening tool, the test has its limitations. The Shield test exhibits a 13% false negative rate, meaning it could miss some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback